|
|
amine metabolic process
|
GO:0009308 |
45 |
0.438
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.397
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.381
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.308
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.287
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.244
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.222
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.220
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.218
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.212
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.199
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.199
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.176
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.167
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.160
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.157
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.155
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.152
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.144
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.140
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.139
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.136
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.133
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.130
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.128
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.126
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.120
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.119
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.118
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.115
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.115
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.105
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.104
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.100
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.096
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.096
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.092
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.090
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.089
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.088
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.088
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.086
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.086
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.085
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.084
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.082
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.081
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.081
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.081
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.080
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.078
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.077
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.077
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.075
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.074
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.073
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.072
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.072
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.070
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.069
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.069
|
|
|
|
negative regulation of endothelial cell apoptotic process
|
GO:2000352 |
7 |
0.068
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.068
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.068
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.065
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.064
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.064
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.064
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.063
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.062
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.062
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.062
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.062
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.062
|
Mouse |
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.062
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.062
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.061
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.060
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.060
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.059
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.059
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.058
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.057
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.056
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.056
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.055
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.055
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.055
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.055
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.054
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.054
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.052
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.052
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.052
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.052
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.051
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.050
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.050
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.050
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.050
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.049
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.048
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.048
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.048
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.048
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.047
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.047
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.046
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.046
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.046
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.046
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.045
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.045
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.045
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.044
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.044
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.044
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.044
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.043
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.042
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.042
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.042
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.042
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.042
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.042
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.041
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.041
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.040
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.040
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.039
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.038
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.038
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.038
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.038
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.038
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.038
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.037
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.037
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.037
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
22 |
0.037
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.037
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.037
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.037
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.037
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.036
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.036
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.036
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.036
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.036
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.036
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.035
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.035
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.035
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.035
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.035
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.035
|
|
|
|
regulation of endothelial cell apoptotic process
|
GO:2000351 |
9 |
0.035
|
Mouse |
|
|
endocytosis
|
GO:0006897 |
168 |
0.035
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.035
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.035
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.034
|
|
|
|
regulation of cytokine secretion involved in immune response
|
GO:0002739 |
4 |
0.034
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.034
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.034
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.034
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.034
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.034
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.033
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.033
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.033
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.033
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.033
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.033
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.033
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.033
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.033
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.032
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.032
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.032
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.032
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.032
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.032
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.032
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.032
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.031
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.031
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.031
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.031
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.031
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.031
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.031
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.031
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.031
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.030
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.030
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.030
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.030
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.030
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.030
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.030
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.029
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.029
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.029
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.029
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.029
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.029
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.029
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.029
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.029
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.029
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.029
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.029
|
|
|
|
regulation of vasculogenesis
|
GO:2001212 |
9 |
0.029
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.029
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.029
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.029
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.029
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.029
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.029
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.029
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.029
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.029
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.029
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.028
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.028
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.028
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.028
|
|
|
|
response to immune response of other organism involved in symbiotic interaction
|
GO:0052564 |
3 |
0.028
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.028
|
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.028
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.028
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.028
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.028
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.028
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.028
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.027
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.027
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.027
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.027
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.027
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.027
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.027
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.027
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.027
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.027
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.027
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.027
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.026
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.026
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.026
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.026
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.026
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.026
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.026
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.026
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.026
|
Mouse |
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.026
|
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
60 |
0.025
|
|
|
|
ascending aorta development
|
GO:0035905 |
3 |
0.025
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.025
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.025
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.025
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.025
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.025
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.025
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.025
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.025
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.025
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.025
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.025
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.025
|
|
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
40 |
0.025
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.025
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.024
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.024
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.024
|
|
|
|
cell migration involved in coronary angiogenesis
|
GO:0060981 |
1 |
0.024
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.024
|
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
9 |
0.024
|
Mouse |
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.024
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.024
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.024
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.024
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.024
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.024
|
|
|
|
smooth muscle cell chemotaxis
|
GO:0071670 |
2 |
0.024
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.024
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.023
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.023
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.023
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.023
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.023
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.023
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.023
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.023
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.023
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.023
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.023
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.023
|
|
|
|
glomerular mesangial cell proliferation
|
GO:0072110 |
3 |
0.023
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.022
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.022
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.022
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.022
|
|
|
|
glycosaminoglycan metabolic process
|
GO:0030203 |
34 |
0.022
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.022
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.022
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.022
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.022
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.022
|
|
|
|
cytokine secretion involved in immune response
|
GO:0002374 |
6 |
0.022
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.022
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.022
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.022
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.022
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.022
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.022
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.022
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.022
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.021
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.021
|
|
|
|
vascular endothelial growth factor receptor signaling pathway
|
GO:0048010 |
24 |
0.021
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.021
|
|
|
|
kidney vasculature development
|
GO:0061440 |
15 |
0.021
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.021
|
|
|
|
negative regulation of reproductive process
|
GO:2000242 |
31 |
0.021
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.021
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.021
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.021
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.021
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.021
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.021
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.021
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.021
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.021
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.021
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.021
|
|
|
|
regulation of cytokine production involved in immune response
|
GO:0002718 |
26 |
0.021
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.021
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.021
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.021
|
|
|
|
detection of stimulus involved in sensory perception
|
GO:0050906 |
44 |
0.021
|
|
|
|
positive regulation of cytokine secretion involved in immune response
|
GO:0002741 |
2 |
0.021
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.021
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.021
|
|
|
|
aminoglycan metabolic process
|
GO:0006022 |
34 |
0.021
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.020
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.020
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.020
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.020
|
|
|
|
positive regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:0035793 |
1 |
0.020
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.020
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.020
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.020
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.020
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.020
|
|
|
|
mucopolysaccharide metabolic process
|
GO:1903510 |
25 |
0.020
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.020
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.020
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.020
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.020
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.020
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.020
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.020
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.020
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.020
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.020
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.020
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.020
|
|
|
|
positive regulation of peptidyl serine phosphorylation
|
GO:0033138 |
25 |
0.019
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.019
|
|
|
|
regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:1900238 |
1 |
0.019
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.019
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.019
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.019
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.019
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.019
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.019
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.019
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.019
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.019
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.019
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.019
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.019
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.019
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.019
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.019
|
|
|
|
positive regulation of intracellular protein transport
|
GO:0090316 |
42 |
0.019
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.019
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.019
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.018
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.018
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.018
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.018
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.018
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.018
|
Mouse |
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.018
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.018
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.018
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.018
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.018
|
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.018
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.018
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.018
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.018
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.018
|
|
|
|
positive regulation of protein localization to nucleus
|
GO:1900182 |
30 |
0.018
|
|
|
|
regulation of blood vessel remodeling
|
GO:0060312 |
3 |
0.018
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.018
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.018
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.017
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.017
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.017
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.017
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.017
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.017
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.017
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.017
|
Mouse |
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.017
|
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
30 |
0.017
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.017
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.017
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.017
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.017
|
|
|
|
regulation of mesonephros development
|
GO:0061217 |
24 |
0.017
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.017
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.017
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.017
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.017
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.017
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.017
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.017
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.017
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.017
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.017
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.017
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.017
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.017
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.017
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.017
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.017
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.016
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.016
|
|
|
|
pro t cell differentiation
|
GO:0002572 |
3 |
0.016
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.016
|
|
|
|
detection of mechanical stimulus involved in sensory perception
|
GO:0050974 |
23 |
0.016
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.016
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.016
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.016
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.016
|
|
|
|
smooth muscle tissue development
|
GO:0048745 |
22 |
0.016
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.016
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.016
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.016
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.016
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.016
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.016
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.016
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.016
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.016
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.016
|
|
|
|
regulation of cell migration involved in sprouting angiogenesis
|
GO:0090049 |
4 |
0.016
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.016
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.016
|
|
|
|
cellular response to thyroid hormone stimulus
|
GO:0097067 |
1 |
0.016
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.016
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.016
|
|
|
|
vegf activated neuropilin signaling pathway
|
GO:0038190 |
2 |
0.016
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.016
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.016
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.016
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.016
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.016
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.016
|
|
|
|
renal system process involved in regulation of blood volume
|
GO:0001977 |
4 |
0.015
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.015
|
|
|
|
detection of mechanical stimulus involved in equilibrioception
|
GO:0050973 |
2 |
0.015
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.015
|
|
|
|
cellular response to vascular endothelial growth factor stimulus
|
GO:0035924 |
11 |
0.015
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.015
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.015
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.015
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.015
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.015
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.015
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.015
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.015
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.015
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.015
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.015
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.015
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.015
|
|
|
|
cardiac atrium development
|
GO:0003230 |
24 |
0.015
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.015
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.015
|
|
